Moderna, Inc. (MRNA) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Moderna, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.952 Good day and thank you for standing by. Welcome to the Moderna First Quarter 2025 conference 00:00:03.952 -- 00:00:07.493 call. At this time, all participants are in a listen-only mode. 00:00:07.493 -- 00:00:10.515 After the speaker's presentation, there'll be a question and answer session. 00:00:10.515 -- 00:00:13.816 To ask a question during the session, you'll need to press star 1-1 on your telephone. 00:00:13.816 -- 00:00:16.737 You will then hear an automated message advising your hand is raised. 00:00:16.737 -- 00:00:19.538 To withdraw your question, please press star 1-1 again. 00:00:19.538 -- 00:00:22.098 Please be advised today's conference is being recorded. 00:00:22.098 -- 00:00:24.979 I would now like to hand the conference over to your speaker today, Lavina Tulukdar, 00:00:24.979 -- 00:00:28.421 Head of Investor Relations at Moderna. Please go ahead. 00:00:28.421 -- 00:00:32.842 Thank you, Kevin. Good morning, everyone. And thank you for joining us on today's call 00:00:32.842 -- 00:00:38.103 to discuss Moderna's first quarter 2025 financial results and business 00:00:38.103 -- 00:00:43.305 updates. You can access the press release issued this morning, as well as the slides 00:00:43.305 -- 00:00:48.446 that we will be reviewing by going to the investor section of our website. 00:00:48.446 -- 00:00:53.687 On today's call are Sivan Bansal, our chief executive officer, Stephen Hogue, 00:00:53.687 -- 00:00:58.290 our president, and Jamie Mock, our chief financial officer. 00:00:58.290 -- 00:01:03.331 Before we begin, please note that this conference call will include forward-looking statements 00:01:03.331 -- 00:01:08.413 made pursuant to the safe harbor provisions of the Private Securities Litigation 00:01:08.413 -- 00:01...